 | • レポートコード：MR2211MG10082 • 出版社/出版日：Market Monitor Global / 2022年11月 • レポート形態：英文、PDF、77ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：機械・装置 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥625,300 (USD4,225) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、コンパニオン診断端末のグローバル市場規模と予測を記載しています。・コンパニオン診断端末のグローバル市場：売上、2017年-2022年、2023年-2028年 ・コンパニオン診断端末のグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 コンパニオン診断端末のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「分子診断」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 コンパニオン診断端末のグローバル主要企業は、Agilent Technologies、 Almac Group、 ARUP Laboratories, Inc.、 Abbott、 Danaher Corporation、 Thermo Fisher Scientific、 Hologic、 Illumina, Inc.、 Qiagen、 Biomerieux SA、 Roche、 Siemens Healthcare、 Denovo Biopharma、 ResearchDxなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、コンパニオン診断端末のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のコンパニオン診断端末市場：タイプ別、2017年-2022年、2023年-2028年 世界のコンパニオン診断端末市場：タイプ別市場シェア、2021年 ・分子診断、免疫診断 世界のコンパニオン診断端末市場：用途別、2017年-2022年、2023年-2028年 世界のコンパニオン診断端末市場：用途別市場シェア、2021年 ・腫瘍学、循環器疾患、中枢神経系、その他 世界のコンパニオン診断端末市場：地域・国別、2017年-2022年、2023年-2028年 世界のコンパニオン診断端末市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるコンパニオン診断端末のグローバル売上、2017年-2022年 ・主要企業におけるコンパニオン診断端末のグローバル売上シェア、2021年 ・主要企業におけるコンパニオン診断端末のグローバル販売量、2017年-2022年 ・主要企業におけるコンパニオン診断端末のグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 Agilent Technologies、 Almac Group、 ARUP Laboratories, Inc.、 Abbott、 Danaher Corporation、 Thermo Fisher Scientific、 Hologic、 Illumina, Inc.、 Qiagen、 Biomerieux SA、 Roche、 Siemens Healthcare、 Denovo Biopharma、 ResearchDx ************************************************************* ・調査・分析レポートの概要 コンパニオン診断端末市場の定義 市場セグメント 世界のコンパニオン診断端末市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のコンパニオン診断端末市場規模 世界のコンパニオン診断端末市場規模：2021年 VS 2028年 世界のコンパニオン診断端末市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのコンパニオン診断端末の売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業のコンパニオン診断端末製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：分子診断、免疫診断 コンパニオン診断端末のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：腫瘍学、循環器疾患、中枢神経系、その他 コンパニオン診断端末の用途別グローバル売上・予測 ・地域別市場分析 地域別コンパニオン診断端末市場規模 2021年と2028年 地域別コンパニオン診断端末売上・予測 北米市場 - アメリカのコンパニオン診断端末市場規模2017年-2028年 - カナダのコンパニオン診断端末市場規模2017年-2028年 - メキシコのコンパニオン診断端末市場規模2017年-2028年 ヨーロッパ市場 - ドイツのコンパニオン診断端末市場規模2017年-2028年 - フランスのコンパニオン診断端末市場規模2017年-2028年 - イギリスのコンパニオン診断端末市場規模2017年-2028年 - イタリアのコンパニオン診断端末市場規模2017年-2028年 - ロシアのコンパニオン診断端末市場規模2017年-2028年 アジア市場 - 中国のコンパニオン診断端末市場規模2017年-2028年 - 日本のコンパニオン診断端末市場規模2017年-2028年 - 韓国のコンパニオン診断端末市場規模2017年-2028年 - 東南アジアのコンパニオン診断端末市場規模2017年-2028年 - インドのコンパニオン診断端末市場規模2017年-2028年 南米市場 - ブラジルのコンパニオン診断端末市場規模2017年-2028年 - アルゼンチンのコンパニオン診断端末市場規模2017年-2028年 中東・アフリカ市場 - トルコのコンパニオン診断端末市場規模2017年-2028年 - イスラエルのコンパニオン診断端末市場規模2017年-2028年 - サウジアラビアのコンパニオン診断端末市場規模2017年-2028年 - UAEのコンパニオン診断端末市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Agilent Technologies、 Almac Group、 ARUP Laboratories, Inc.、 Abbott、 Danaher Corporation、 Thermo Fisher Scientific、 Hologic、 Illumina, Inc.、 Qiagen、 Biomerieux SA、 Roche、 Siemens Healthcare、 Denovo Biopharma、 ResearchDx ... |
Concomitant diagnosis is an in vitro diagnostic technology, which can provide information about the treatment response of patients to specific therapeutic drugs, and help to determine the patient population that can benefit from a certain treatment product, so as to improve the treatment prognosis and reduce the health care expenditure.
This report contains market size and forecasts of Companion Diagnostics Devices in global, including the following market information:
Global Companion Diagnostics Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Companion Diagnostics Devices Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Companion Diagnostics Devices companies in 2021 (%)
The global Companion Diagnostics Devices market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Molecular Diagnosis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Companion Diagnostics Devices include Agilent Technologies, Almac Group, ARUP Laboratories, Inc., Abbott, Danaher Corporation, Thermo Fisher Scientific, Hologic, Illumina, Inc. and Qiagen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Companion Diagnostics Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Companion Diagnostics Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Companion Diagnostics Devices Market Segment Percentages, by Type, 2021 (%)
Molecular Diagnosis
Immunodiagnosis
Global Companion Diagnostics Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Companion Diagnostics Devices Market Segment Percentages, by Application, 2021 (%)
Oncology
Cardiovascular Disease
Central Nervous System
Others
Global Companion Diagnostics Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Companion Diagnostics Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Companion Diagnostics Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Companion Diagnostics Devices revenues share in global market, 2021 (%)
Key companies Companion Diagnostics Devices sales in global market, 2017-2022 (Estimated), (Units)
Key companies Companion Diagnostics Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Agilent Technologies
Almac Group
ARUP Laboratories, Inc.
Abbott
Danaher Corporation
Thermo Fisher Scientific
Hologic
Illumina, Inc.
Qiagen
Biomerieux SA
Roche
Siemens Healthcare
Denovo Biopharma
ResearchDx
1 Introduction to Research & Analysis Reports
1.1 Companion Diagnostics Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Companion Diagnostics Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Companion Diagnostics Devices Overall Market Size
2.1 Global Companion Diagnostics Devices Market Size: 2021 VS 2028
2.2 Global Companion Diagnostics Devices Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Companion Diagnostics Devices Sales: 2017-2028
3 Company Landscape
3.1 Top Companion Diagnostics Devices Players in Global Market
3.2 Top Global Companion Diagnostics Devices Companies Ranked by Revenue
3.3 Global Companion Diagnostics Devices Revenue by Companies
3.4 Global Companion Diagnostics Devices Sales by Companies
3.5 Global Companion Diagnostics Devices Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Companion Diagnostics Devices Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Companion Diagnostics Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Companion Diagnostics Devices Players in Global Market
3.8.1 List of Global Tier 1 Companion Diagnostics Devices Companies
3.8.2 List of Global Tier 2 and Tier 3 Companion Diagnostics Devices Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Companion Diagnostics Devices Market Size Markets, 2021 & 2028
4.1.2 Molecular Diagnosis
4.1.3 Immunodiagnosis
4.2 By Type – Global Companion Diagnostics Devices Revenue & Forecasts
4.2.1 By Type – Global Companion Diagnostics Devices Revenue, 2017-2022
4.2.2 By Type – Global Companion Diagnostics Devices Revenue, 2023-2028
4.2.3 By Type – Global Companion Diagnostics Devices Revenue Market Share, 2017-2028
4.3 By Type – Global Companion Diagnostics Devices Sales & Forecasts
4.3.1 By Type – Global Companion Diagnostics Devices Sales, 2017-2022
4.3.2 By Type – Global Companion Diagnostics Devices Sales, 2023-2028
4.3.3 By Type – Global Companion Diagnostics Devices Sales Market Share, 2017-2028
4.4 By Type – Global Companion Diagnostics Devices Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application – Global Companion Diagnostics Devices Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Cardiovascular Disease
5.1.4 Central Nervous System
5.1.5 Others
5.2 By Application – Global Companion Diagnostics Devices Revenue & Forecasts
5.2.1 By Application – Global Companion Diagnostics Devices Revenue, 2017-2022
5.2.2 By Application – Global Companion Diagnostics Devices Revenue, 2023-2028
5.2.3 By Application – Global Companion Diagnostics Devices Revenue Market Share, 2017-2028
5.3 By Application – Global Companion Diagnostics Devices Sales & Forecasts
5.3.1 By Application – Global Companion Diagnostics Devices Sales, 2017-2022
5.3.2 By Application – Global Companion Diagnostics Devices Sales, 2023-2028
5.3.3 By Application – Global Companion Diagnostics Devices Sales Market Share, 2017-2028
5.4 By Application – Global Companion Diagnostics Devices Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region – Global Companion Diagnostics Devices Market Size, 2021 & 2028
6.2 By Region – Global Companion Diagnostics Devices Revenue & Forecasts
6.2.1 By Region – Global Companion Diagnostics Devices Revenue, 2017-2022
6.2.2 By Region – Global Companion Diagnostics Devices Revenue, 2023-2028
6.2.3 By Region – Global Companion Diagnostics Devices Revenue Market Share, 2017-2028
6.3 By Region – Global Companion Diagnostics Devices Sales & Forecasts
6.3.1 By Region – Global Companion Diagnostics Devices Sales, 2017-2022
6.3.2 By Region – Global Companion Diagnostics Devices Sales, 2023-2028
6.3.3 By Region – Global Companion Diagnostics Devices Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country – North America Companion Diagnostics Devices Revenue, 2017-2028
6.4.2 By Country – North America Companion Diagnostics Devices Sales, 2017-2028
6.4.3 US Companion Diagnostics Devices Market Size, 2017-2028
6.4.4 Canada Companion Diagnostics Devices Market Size, 2017-2028
6.4.5 Mexico Companion Diagnostics Devices Market Size, 2017-2028
6.5 Europe
6.5.1 By Country – Europe Companion Diagnostics Devices Revenue, 2017-2028
6.5.2 By Country – Europe Companion Diagnostics Devices Sales, 2017-2028
6.5.3 Germany Companion Diagnostics Devices Market Size, 2017-2028
6.5.4 France Companion Diagnostics Devices Market Size, 2017-2028
6.5.5 U.K. Companion Diagnostics Devices Market Size, 2017-2028
6.5.6 Italy Companion Diagnostics Devices Market Size, 2017-2028
6.5.7 Russia Companion Diagnostics Devices Market Size, 2017-2028
6.5.8 Nordic Countries Companion Diagnostics Devices Market Size, 2017-2028
6.5.9 Benelux Companion Diagnostics Devices Market Size, 2017-2028
6.6 Asia
6.6.1 By Region – Asia Companion Diagnostics Devices Revenue, 2017-2028
6.6.2 By Region – Asia Companion Diagnostics Devices Sales, 2017-2028
6.6.3 China Companion Diagnostics Devices Market Size, 2017-2028
6.6.4 Japan Companion Diagnostics Devices Market Size, 2017-2028
6.6.5 South Korea Companion Diagnostics Devices Market Size, 2017-2028
6.6.6 Southeast Asia Companion Diagnostics Devices Market Size, 2017-2028
6.6.7 India Companion Diagnostics Devices Market Size, 2017-2028
6.7 South America
6.7.1 By Country – South America Companion Diagnostics Devices Revenue, 2017-2028
6.7.2 By Country – South America Companion Diagnostics Devices Sales, 2017-2028
6.7.3 Brazil Companion Diagnostics Devices Market Size, 2017-2028
6.7.4 Argentina Companion Diagnostics Devices Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Companion Diagnostics Devices Revenue, 2017-2028
6.8.2 By Country – Middle East & Africa Companion Diagnostics Devices Sales, 2017-2028
6.8.3 Turkey Companion Diagnostics Devices Market Size, 2017-2028
6.8.4 Israel Companion Diagnostics Devices Market Size, 2017-2028
6.8.5 Saudi Arabia Companion Diagnostics Devices Market Size, 2017-2028
6.8.6 UAE Companion Diagnostics Devices Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Agilent Technologies
7.1.1 Agilent Technologies Corporate Summary
7.1.2 Agilent Technologies Business Overview
7.1.3 Agilent Technologies Companion Diagnostics Devices Major Product Offerings
7.1.4 Agilent Technologies Companion Diagnostics Devices Sales and Revenue in Global (2017-2022)
7.1.5 Agilent Technologies Key News
7.2 Almac Group
7.2.1 Almac Group Corporate Summary
7.2.2 Almac Group Business Overview
7.2.3 Almac Group Companion Diagnostics Devices Major Product Offerings
7.2.4 Almac Group Companion Diagnostics Devices Sales and Revenue in Global (2017-2022)
7.2.5 Almac Group Key News
7.3 ARUP Laboratories, Inc.
7.3.1 ARUP Laboratories, Inc. Corporate Summary
7.3.2 ARUP Laboratories, Inc. Business Overview
7.3.3 ARUP Laboratories, Inc. Companion Diagnostics Devices Major Product Offerings
7.3.4 ARUP Laboratories, Inc. Companion Diagnostics Devices Sales and Revenue in Global (2017-2022)
7.3.5 ARUP Laboratories, Inc. Key News
7.4 Abbott
7.4.1 Abbott Corporate Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Companion Diagnostics Devices Major Product Offerings
7.4.4 Abbott Companion Diagnostics Devices Sales and Revenue in Global (2017-2022)
7.4.5 Abbott Key News
7.5 Danaher Corporation
7.5.1 Danaher Corporation Corporate Summary
7.5.2 Danaher Corporation Business Overview
7.5.3 Danaher Corporation Companion Diagnostics Devices Major Product Offerings
7.5.4 Danaher Corporation Companion Diagnostics Devices Sales and Revenue in Global (2017-2022)
7.5.5 Danaher Corporation Key News
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Corporate Summary
7.6.2 Thermo Fisher Scientific Business Overview
7.6.3 Thermo Fisher Scientific Companion Diagnostics Devices Major Product Offerings
7.6.4 Thermo Fisher Scientific Companion Diagnostics Devices Sales and Revenue in Global (2017-2022)
7.6.5 Thermo Fisher Scientific Key News
7.7 Hologic
7.7.1 Hologic Corporate Summary
7.7.2 Hologic Business Overview
7.7.3 Hologic Companion Diagnostics Devices Major Product Offerings
7.7.4 Hologic Companion Diagnostics Devices Sales and Revenue in Global (2017-2022)
7.7.5 Hologic Key News
7.8 Illumina, Inc.
7.8.1 Illumina, Inc. Corporate Summary
7.8.2 Illumina, Inc. Business Overview
7.8.3 Illumina, Inc. Companion Diagnostics Devices Major Product Offerings
7.8.4 Illumina, Inc. Companion Diagnostics Devices Sales and Revenue in Global (2017-2022)
7.8.5 Illumina, Inc. Key News
7.9 Qiagen
7.9.1 Qiagen Corporate Summary
7.9.2 Qiagen Business Overview
7.9.3 Qiagen Companion Diagnostics Devices Major Product Offerings
7.9.4 Qiagen Companion Diagnostics Devices Sales and Revenue in Global (2017-2022)
7.9.5 Qiagen Key News
7.10 Biomerieux SA
7.10.1 Biomerieux SA Corporate Summary
7.10.2 Biomerieux SA Business Overview
7.10.3 Biomerieux SA Companion Diagnostics Devices Major Product Offerings
7.10.4 Biomerieux SA Companion Diagnostics Devices Sales and Revenue in Global (2017-2022)
7.10.5 Biomerieux SA Key News
7.11 Roche
7.11.1 Roche Corporate Summary
7.11.2 Roche Companion Diagnostics Devices Business Overview
7.11.3 Roche Companion Diagnostics Devices Major Product Offerings
7.11.4 Roche Companion Diagnostics Devices Sales and Revenue in Global (2017-2022)
7.11.5 Roche Key News
7.12 Siemens Healthcare
7.12.1 Siemens Healthcare Corporate Summary
7.12.2 Siemens Healthcare Companion Diagnostics Devices Business Overview
7.12.3 Siemens Healthcare Companion Diagnostics Devices Major Product Offerings
7.12.4 Siemens Healthcare Companion Diagnostics Devices Sales and Revenue in Global (2017-2022)
7.12.5 Siemens Healthcare Key News
7.13 Denovo Biopharma
7.13.1 Denovo Biopharma Corporate Summary
7.13.2 Denovo Biopharma Companion Diagnostics Devices Business Overview
7.13.3 Denovo Biopharma Companion Diagnostics Devices Major Product Offerings
7.13.4 Denovo Biopharma Companion Diagnostics Devices Sales and Revenue in Global (2017-2022)
7.13.5 Denovo Biopharma Key News
7.14 ResearchDx
7.14.1 ResearchDx Corporate Summary
7.14.2 ResearchDx Business Overview
7.14.3 ResearchDx Companion Diagnostics Devices Major Product Offerings
7.14.4 ResearchDx Companion Diagnostics Devices Sales and Revenue in Global (2017-2022)
7.14.5 ResearchDx Key News
8 Global Companion Diagnostics Devices Production Capacity, Analysis
8.1 Global Companion Diagnostics Devices Production Capacity, 2017-2028
8.2 Companion Diagnostics Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Companion Diagnostics Devices Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Companion Diagnostics Devices Supply Chain Analysis
10.1 Companion Diagnostics Devices Industry Value Chain
10.2 Companion Diagnostics Devices Upstream Market
10.3 Companion Diagnostics Devices Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Companion Diagnostics Devices Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer